Picture of Oncozenge AB logo

ONCOZ — Oncozenge AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Oncozenge Files Patent Application For Strengthened IP Protection For Bupizenge

Feb 7 (Reuters) - Oncozenge AB  ONCOZ.ST :
    * ONCOZENGE FILES PATENT APPLICATION FOR STRENGTHENED IP
PROTECTION FOR BUPIZENGE™
    * NEW PATENT WILL PROVIDE STRENGTHENED IP PROTECTION FOR
STRATEGIC
PARTNERS AND LICENSEES UPON APPROVAL
    * WITH NEW PATENT APPLICATION, BUPIZENGE™ AS PAIN RELIEVER
FOR
ORAL MUCOSITIS, OR FUTURE VARIANTS OF BUPIZENGE™ FOR OTHER
INDICATIONS, WILL BE PATENT PROTECTED UNTIL 2045, SUBJECT TO
APPROVAL.

Source text for Eikon:  ID:nWkr1FcwWb 
Further company coverage:  ONCOZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Oncozenge AB

See all news